litlas
Log inCreate account

Michael J. Krowka

Active 1985–2025

90
Papers
21,534
Citations
64
h-index
88
i10-index

Citations

Citations per year for Michael J. Krowka1984: 1 citations1985: 1 citations1986: 1 citations1987: 1 citations1988: 2 citations1989: 13 citations1990: 12 citations1991: 10 citations1992: 20 citations1993: 8 citations1994: 15 citations1995: 45 citations1996: 33 citations1997: 29 citations1998: 31 citations1999: 29 citations2000: 58 citations2001: 43 citations2002: 53 citations2003: 53 citations2004: 103 citations2005: 77 citations2006: 90 citations2007: 84 citations2008: 120 citations2009: 87 citations2010: 131 citations2011: 108 citations2012: 209 citations2013: 175 citations2014: 137 citations2015: 75 citations2016: 86 citations2017: 61 citations2018: 64 citations2019: 318 citations2020: 575 citations2021: 468 citations2022: 349 citations2023: 221 citations2024: 398 citations2025: 131 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,455 citing papers, 30.3% of this breakdownUnited Kingdom: 363 citing papers, 7.5% of this breakdownFrance: 356 citing papers, 7.4% of this breakdownGermany: 291 citing papers, 6.1% of this breakdownChina: 273 citing papers, 5.7% of this breakdownCanada: 218 citing papers, 4.5% of this breakdownItaly: 206 citing papers, 4.3% of this breakdownSpain: 167 citing papers, 3.5% of this breakdownNetherlands: 152 citing papers, 3.2% of this breakdownJapan: 129 citing papers, 2.7% of this breakdownSwitzerland: 114 citing papers, 2.4% of this breakdownAustralia: 108 citing papers, 2.2% of this breakdown
0%30.3%Other 20.2%

Institutions

Fields

  • Medicine93.2%
  • Biochemistry, Genetics and Molecular Biology4.4%
  • Immunology and Microbiology0.6%
  • Engineering0.5%
  • Computer Science0.3%
  • Neuroscience0.2%
  • Other0.8%

Topics

  • Pulmonary Hypertension Research and Treatments20.9%
  • Liver Disease and Transplantation6.6%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis4.9%
  • Cardiovascular Function and Risk Factors4.5%
  • Organ Transplantation Techniques and Outcomes3.7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.1%
  • Other56.3%

Coauthors

All papers

Open in search
  1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

    Authors: Gérald Simonneau, David Montani, David S. Celermajer, Christopher P. Denton, Michael Α. Gatzoulis, Michael J. Krowka, Paul Williams, Rogério Souza - European Respiratory Journal 2018 cited by 3,806

  2. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension

    Authors: Justin Boike, Bartley Thornburg, Sumeet K. Asrani, Michael B. Fallon, Brett E. Fortune, Manhal Izzy, Elizabeth C. Verna, Juan G. Abraldeṣ, Andrew S. Allegretti, Jasmohan S. Bajaj, Scott W. Biggins, Michael D. Darcy, Maryjane A. Farr, Khashayar Farsad, Guadalupe García–Tsao, Shelley Hall, Caroline C. Jadlowiec, Michael J. Krowka, Jeanne M. LaBerge, Edward Lee, David C. Mulligan, Mitra K. Nadim, Patrick G. Northup, Riad Salem, Joseph J. Shatzel, Cathryn J. Shaw, Douglas A. Simonetto, Jonathan Susman, K. Kolli, Lisa B. VanWagner - Clinical Gastroenterology and Hepatology 2021 cited by 221

  3. International Liver Transplant Society Practice Guidelines

    Authors: Michael J. Krowka, Michael B. Fallon, Steven M. Kawut, Valentin Fuhrmann, Julie K. Heimbach, Michael A. E. Ramsay, Olivier Sitbon, Ronald J. Sokol - Transplantation 2016 cited by 443

  4. Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial

    Authors: Olivier Sitbon, Jaime Bosch, Emmanuelle Cottreel, Dénes Csonka, Pascal de Groote, Marius M. Hoeper, Nick H. Kim, Nicolas Martin, Laurent Savale, Michael J. Krowka - The Lancet Respiratory Medicine 2019 cited by 182

  5. Portopulmonary Hypertension

    Authors: Michael J. Krowka, Dave P. Miller, Robyn J. Barst, Darren B. Taichman, Raed A. Dweik, David B. Badesch, Michael D. McGoon - CHEST Journal 2011 cited by 296

  6. Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates

    Authors: Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, Steven Zacks, Kari E. Roberts, Vijay H. Shah, Neil Kaplowitz, Lisa Forman, Keith Wille, Steven M. Kawut - Gastroenterology 2008 cited by 307

  7. Hepatopulmonary Syndrome — A Liver-Induced Lung Vascular Disorder

    Authors: Roberto Rodríguez-Roisin, Michael J. Krowka - New England Journal of Medicine 2008 cited by 676

  8. Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis

    Authors: Hassan F. Nadrous, Patricia A. Pellikka, Michael J. Krowka, Karen L. Swanson, Nithima Chaowalit, Paul A. Decker, Jay H. Ryu - CHEST Journal 2004 cited by 434

  9. Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups

    Authors: Karen L. Swanson, Russell H. Wiesner, Scott L. Nyberg, Charles B. Rosen, Michael J. Krowka - American Journal of Transplantation 2008 cited by 344

  10. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

    Authors: Vivek Iyer, Dinesh Apala, Bibek Pannu, Aditya Kotecha, Waleed Brinjikji, Michael D. Leise, Patrick S. Kamath, Sanjay Misra, Kebede H. Begna, Rodrigo Cartin‐Ceba, Hilary M. DuBrock, Michael J. Krowka, Erin K. O’Brien, Rajiv K. Pruthi, Darrell R. Schroeder, Karen L. Swanson - Mayo Clinic Proceedings 2018 cited by 124

  11. BMP9/10 in Pulmonary Vascular Complications of Liver Disease

    Authors: Elizabeth R. Rochon, Michael J. Krowka, Sonja Bartolome, Gustavo A. Heresi, Todd M. Bull, Kari E. Roberts, Anna R. Hemnes, Kimberly A. Forde, Karen Krok, Mamta Patel, Grace Lin, Megan McNeil, Nadine Al‐Naamani, Beth L. Roman, Paul B. Yu, Michael B. Fallon, Mark T. Gladwin, Steven M. Kawut - American Journal of Respiratory and Critical Care Medicine 2020 cited by 57

  12. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry

    Authors: Héctor Cajigas, Charles D. Burger, Rodrigo Cartin‐Ceba, Hilary M. DuBrock, Karen L. Swanson, Hugo E. Vargas, Andrew P. Keaveny, Kymberly D. Watt, Michael J. Krowka - Mayo Clinic Proceedings 2022 cited by 21

  13. Diagnosis and differential assessment of pulmonary arterial hypertension

    Authors: Robyn J. Barst, Michael D. McGoon, Adam Torbicki, Olivier Sitbon, Michael J. Krowka, Horst Olschewski, Seán Gaine - Journal of the American College of Cardiology 2004 cited by 992

  14. Pulmonary–Hepatic vascular Disorders (PHD)

    Authors: R Rodríguez-Roisín, Michael J. Krowka, P Hervé, Michael B. Fallon - European Respiratory Journal 2004 cited by 796

  15. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation

    Authors: Michael J. Krowka, David J. Plevak, James Y. Findlay, Charles B. Rosen, Russell H. Wiesner, Ruud A. F. Krom - Liver Transplantation 2000 cited by 610

  16. Portopulmonary hypertension: Results from a 10-year screening algorithm

    Authors: Michael J. Krowka, Karen L. Swanson, Robert P. Frantz, Michael D. McGoon, Russell H. Wiesner - Hepatology 2006 cited by 385

  17. Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension

    Authors: Megan M. Lowery, Nicholas S. Hill, Lu Wang, Erika B. Rosenzweig, Aparna Bhat, Serpil C. Erzurum, J. Emanuel Finet, Christine Jellis, Sunjeet Kaur, Deborah Kwon, R Nawabit, Milena Radeva, Gerald J. Beck, Robert P. Frantz, Paul M. Hassoun, Anna R. Hemnes, Evelyn M. Horn, Jane A. Leopold, Franz Rischard, Reena Mehra, Nicholas S. Hill, Lei Xiao, Yongping Fu, Lisa Postow, Barry Schmetter, K. Stanton, Xuefei Tian, Michael P. Gray, Banny S. Wong, Jane A. Leopold, Aaron B. Waxman, Marcelo F. DiCarli, Laurie Lawler, Bradley A. Maron, Sergio A. Segrera, David M. Systrom, Peng Yu, Erika B. Rosenzweig, Selim M. Arcasoy, David J. Brady, Wendy K. Chung, David A. Payne, Gabriele Grünig, Jennifer Haythe, U. Krishnan, Evelyn M. Horn, Kemal M. Akat, Alain Borczuk, Richard B. Devereux, J. B. Gordon, Robert J. Kaner, Maria Karas, Jeff Min, Nupoor Narula, Michelle L. Ricketts, I. Sobol, Robert Spiera, Harsimran Singh, Thomas Tuschl, Jonathan W. Weinsaft, Paul M. Hassoun, Stephen C. Mathai, Kathleen C. Barnes, R.L. Damico, Blessing Enobun, Lei Gao, Marc K. Halushka, David A. Kass, Todd M. Kolb, T. Lin, Ryan J. Tedford, Stefan L. Zimmerman, Robert P. Frantz, Atta Behfar, Linda Block, Barry A. Borlaug, Louise A. Durst, Thomas A. Foley, Thomas Hammer, Bruce D. Johnson, Geoffrey B. Johnson, Garvan C. Kane, Michael J. Krowka, Annette McNallan, Thomas P. Olson, Margaret M. Redfield, Kristi Rohwer, André Terzic, Eric E. Williamson, Franz Rischard, Jason X.‐J. Yuan, Aiden Abidov, Joe G. N. Garcia, Arlette G. Cordery, Ankit A. Desai, H. Erickson, Lene Hansen, Zain Khalpey, Kenneth S. Knox, Yves A. Lussier and 57 more - Journal of the American College of Cardiology 2023 cited by 26

  18. Updated Clinical Classification of Pulmonary Hypertension

    Authors: Gérald Simonneau, Ivan M. Robbins, Maurice Beghetti, Richard N. Channick, Marion Delcroix, Christopher P. Denton, C. Gregory Elliott, Seán Gaine, Mark T. Gladwin, Zhi‐Cheng Jing, Michael J. Krowka, David Langleben, Norifumi Nakanishi, Rogério Souza - Journal of the American College of Cardiology 2009 cited by 2,071

  19. Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease

    Authors: Kari E. Roberts, Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, Inga Peter, Hocine Tighiouart, James A. Knowles, Daniel Rabinowitz, Raymond L. Benza, David B. Badesch, Darren B. Taichman, Evelyn M. Horn, Steven Zacks, Neil Kaplowitz, Steven M. Kawut - American Journal of Respiratory and Critical Care Medicine 2009 cited by 232

  20. Pulmonary Arteriovenous Malformations

    Authors: Rodrigo Cartin‐Ceba, Karen L. Swanson, Michael J. Krowka - CHEST Journal 2013 cited by 181

  21. Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Trial

    Authors: Steven M. Kawut, Susan S. Ellenberg, Michael J. Krowka, David S. Goldberg, Hugo E. Vargas, David Koch, Tiffany Sharkoski, Nadine Al‐Naamani, Alyson N. Fox, Robert S. Brown, Joshua Levitsky, Jae K. Oh, Grace Lin, Nianfu Song, Carl Mottram, Margaret F. Doyle, David E. Kaplan, Samir Gupta, Michael B. Fallon - Liver Transplantation 2019 cited by 46

  22. Pulmonary Complications of Portal Hypertension

    Authors: Rodrigo Cartin‐Ceba, Michael J. Krowka - Clinics in Liver Disease 2019 cited by 44

  23. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg

    Authors: Hilary M. DuBrock, James Runo, Corey J. Sadd, Charles D. Burger, Rodrigo Cartin‐Ceba, Charles B. Rosen, Timuçin Taner, Scott L. Nyberg, Julie K. Heimbach, James Y. Findlay, Michael J. Krowka - Transplantation Direct 2020 cited by 39

  24. Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)

    Authors: Nadine Al‐Naamani, Michael J. Krowka, Kimberly A. Forde, Karen Krok, Rui Feng, Gustavo A. Heresi, Raed A. Dweik, Sonja Bartolome, Todd Bull, Kari E. Roberts, Eric D. Austin, Anna R. Hemnes, Mamta Patel, Jae K. Oh, Grace Lin, Margaret F. Doyle, Nina Denver, Ruth Andrew, Margaret R. MacLean, Michael B. Fallon, Steven M. Kawut, , for the Pulmonary Vascular Complications of Liver Disease Study Group - Hepatology 2020 cited by 39